43000 shareholders were shocked! 16percent of vaccine glass bottle cattle stock flash in 5 minutes

category:Finance
 43000 shareholders were shocked! 16percent of vaccine glass bottle cattle stock flash in 5 minutes


On October 21, on the basis of the trading limit of the previous day, Zhengchuan shares, which had a small and low opening, rose steadily, and rose to 9% during the period. When the market closed (14:44), a large number of sales orders gushed out, smashing the stock price straight down, dropping 9% at the lowest point, and then pulling it up and down again. Finally, it closed down by 8.30% and the intraday amplitude exceeded 18%.

By the end of the day, Zhengchuan shares closed at 86.86 yuan / share, with a turnover rate of 13.88%, a turnover of 2.005 billion yuan and a market value of 13.13 billion yuan. According to the data of Dongfang fortune, as of July 31, this year, there were 43000 shares in the stock. In the list of its top ten circulating shareholders (as of June 30 this year), there were only two institutions, and the remaining eight shareholders were all natural persons.

For todays Zhengchuan stock market performance, stock bar netizens burst into a pot, some stock friends exclaimed: heart disease can be scared out, and stock friends today killed: dizzy ah!!! Will the 1000 shares of 98 be on guard? It has been commented that the scenery on the top of the mountain is good! Have stood up straight, there are netizens crying: the list did not see, the final fall when the automatic purchase! What about tomorrow? 102 yuan successfully stood guard, from earning a few hundred yuan to paying more than 70000 yuan. What have I experienced today?.

However, one of the shareholders saw the clue of the main force early. At 10:46 a.m., he made a speech to remind him: today, the turnover rate has reached 6%,... We should pay attention to the risk of main shipment.

Zhengchuan announced that it produced glass bottles

There is still uncertainty about whether it can be used as a vaccine

On October 20, Zhengchuan shares had been listed on the dragon and tiger list due to the accumulated deviation value of 20% in three consecutive trading days. After hours, Zhengchuan Co., Ltd. issued a related announcement on the abnormal fluctuation of stock price. At present, the company only produces medium borosilicate bottles through outsourcing, and the proportion of medium borosilicate glass bottles in the companys product structure is relatively low. At the same time, according to the actual situation, even if the company receives the relevant purchase orders in a short time, the estimated purchase quantity is relatively limited, and the actual benefit is limited, which will not have a significant impact on the companys business results. At present, a medium boron glass tube furnace of the company is in the construction stage, and there is no formal mass production. Even if the production is officially carried out, the output is relatively limited, and the market share is not high in the short term. The national implementation of consistency evaluation, drug selection, packaging material stability test and so on need to be verified for a long time. Whether the companys self-made borosilicate glass tube can be used for vaccine in the future is also uncertain.

The stock price has risen more than three times in half a year, and the real controllers family wealth has increased by 4.2 billion

According to the public information, Zhengchuan Co., Ltd., formerly known as Tangkou glass factory in Jiangbei County, Chongqing, was established in 1989. Since 31 years, the company has been focusing on the R & D, production and sales of pharmaceutical packaging materials such as pharmaceutical glass tube bottles. Its pharmaceutical manufacturing industry accounts for more than 99% of its revenue.

At the beginning of this year, China was attacked by the epidemic, which affected the operation and stock price of Zhengchuan stock, which was actually controlled by Deng Yongs family.

By August 4, the stock price was up to 108 yuan / share, up 556.53% from 16.45 yuan / share on the eve of the launch of this round of market, and it has soared more than 800% from the lowest point, setting a new record for Zhengchuan shares.

Zhengchuan shares was listed on August 22, 2017, with the initial price of 14.32 yuan per share. In 2018, the company implemented the dividend plan of converting 10 shares into 4 shares. On this basis, the stock price on August 4 this year rose 9.63 times compared with the issuing price.

On July 27, the company issued an announcement while Zhengchuan stock price soared. Recently, the company has been concerned about the market rumor about the shortage of vaccine glass bottles reported by the media. At present, the company has not received the relevant batch purchase order. At present, the companys borosilicate tube products are in the stage of technical research and development and have not been formally mass produced. Only through outsourcing, the company produces medium borosilicate glass bottles, and the proportion of medium borosilicate glass bottles in the companys product structure is relatively low. At the same time, according to the current actual situation, even if the company receives the relevant purchase orders in a short period of time, the estimated purchase quantity is relatively limited, and the actual benefit is limited, which will not have a significant impact on the companys operating results.

On August 4, the stock price began to fall after it peaked. On September 14, it was 47.27 yuan per share, a recent low. At this time, A-share market vaccine concept stocks have been substantially adjusted.

On September 15, with the concept of vaccine stocks rising again, the stock price of Zhengchuan returned to the upward trend. On September 15, the stock price was up and down, and from September 22 to 24, the stock price was up and down for three consecutive days. In todays session, it rose again to the previous high near 103 yuan / share.

That night, Zhengchuan shares also disclosed the shareholders plan to reduce their holdings.

September 25, A-share market adjustment, individual stocks fell more than rose less. Zhengchuan shares still closed up 2.45%, with a share price of 71.90 yuan / share, a cumulative increase of more than 3.60 times compared with 15.63 yuan / share on March 24 this year.

The sharp rise in the stock price led to a rapid increase in the market value of Zhengchuan shares. As of September 25, the market value of the company was 10.871 billion yuan, an increase of about 8.508 billion yuan compared with March 24. At the end of the second quarter, the companys total assets were 1.305 billion yuan.

Up to now, Deng Yongs family, the actual controller of Zhengchuan shares, directly and indirectly holds 50.27% of the companys shares. As of September 25, the shareholding wealth was 5.465 billion yuan, an increase of about 4.277 billion yuan in half a year.

Performance began to decline last year

The top five largest buyers were 27.202 million yuan from Ping An Securities Co., Ltd. Yinchuan Fenghuang North Street securities business department, 26.782 million yuan from the first securities business department of Tuanjie Road, Lhasa of Dongfang Fortune Securities Co., Ltd., and the remaining business departments were about 20 million yuan. The total net sales of the top 5 buyers and top 5 sellers were 31.9484 million yuan.

It is worth noting that although Zhengchuan is one of the leading enterprises in the domestic pharmaceutical glass tube bottle industry, the companys performance has declined since last year. In 2019, the actual operating revenue was 521 million yuan, a year-on-year decrease of 12.54%; the net profit attributable to the parent company was 61.567 million yuan, with a year-on-year decrease of 26.23%.

In the first half of this year, the companys performance further declined under the influence of the epidemic. By the end of June, the actual operating revenue was 256 million yuan, a year-on-year decrease of 4.46%; the net profit attributable to the parent company was 34.92 million yuan, with a year-on-year increase of 9.22%. Every editor noticed that the profitability of Zhengchuan shares has been declining year by year in the past three years. From 2017 to 2019, the gross profit rates are 31.65%, 28.67% and 27.14% respectively. In the first half of this year, the companys gross margin fell to 26.15%. To upgrade its existing production line, Zhengchuan also announced on July 30 that it plans to issue convertible bonds to raise 405 million yuan. Among them, 375 million yuan is planned to be invested in the production project of China borosilicate medicinal glass. (this article is for reference only and does not constitute an investment proposal. Therefore, the operational risk shall be borne by ourselves) source: Daily Economic News Editor: Yang Bin_ NF4368

In the first half of this year, the companys performance fell further under the influence of the epidemic. By the end of June, the actual operating income was 256million yuan, down 4.46% year on year; the net profit attributable to the parent company was RMB 34.92 million, an increase of 9.22% year-on-year.

Every editor noticed that the profitability of Zhengchuan shares has been declining year by year in the past three years. From 2017 to 2019, the gross profit rates are 31.65%, 28.67% and 27.14% respectively. In the first half of this year, the companys gross margin fell to 26.15%. To upgrade its existing production line, Zhengchuan also announced on July 30 that it plans to issue convertible bonds to raise 405 million yuan. Among them, 375 million yuan is planned to be invested in the production project of China borosilicate medicinal glass.

(this article is for reference only and does not constitute an investment proposal. Therefore, the operation risk shall be borne by yourself.)